Study Finds Wegovy Reduces COVID-19 Death Risk by One-Third
Summary: A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%. The study followed more than 17,000 participants with heart …